ZJJF's subsidiary has obtained the approval notice for the listing application of fumaric acid vorinostat chemical raw materials
I'm PortAI, I can summarize articles.
ZJJF's subsidiary Anhui Jianfeng Beika Pharmaceutical Co., Ltd. recently received the notice of approval for the marketing application of the chemical raw material drug Fumaric Acid Vorinostat from the National Medical Products Administration. This drug is used to treat reflux esophagitis and meets the relevant national review technical standards, marking its availability for sale in the domestic market and aiding the subsidiary's business expansion
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments